Intravenous Ferrous Sucrose Versus Oral Ferrous Sulphate in Treatment of Postpartum Iron Difficiency Anaemia: A Randomized Controlled Clinical Trial
Not Applicable
Recruiting
- Conditions
- Fertility-female
- Registration Number
- PACTR201602001468135
- Lead Sponsor
- menoufia university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Postpartum Iron Difficiency Anaemia with haemoglobin <9g/dL and serum ferritin <15microgram/l
Exclusion Criteria
Iron intolerance-asthma-seizures-renal disease-hepatic disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of intravenous ferrous sucrose in treating postpartum iron deficiency anemia compared to oral ferrous sulphate?
How does intravenous ferrous sucrose compare to oral ferrous sulphate in efficacy and safety for postpartum iron deficiency anemia patients?
What biomarkers are associated with response to intravenous iron therapy in postpartum women with iron deficiency anemia?
What are the potential adverse events of intravenous ferrous sucrose in postpartum women and how are they managed compared to oral ferrous sulphate?
Are there any combination therapies or alternative iron formulations that enhance treatment outcomes for postpartum iron deficiency anemia compared to ferrous sucrose and ferrous sulphate?